EGR1 and myelodysplastic syndrome: Interestingly, the expression of megakaryocyte-erythroid progenitor (MEP) marker EGR1 appears to be repressed in MDS group (Fig. 3C#2), which is consistent with that anemia and thrombocytopenia are generally found in MDS patients.